newsmetry
rusign inget started
macro

Leerink Partners Raises McKesson Price Target to $1200 a Share

Dow Jones Newswires reports Leerink Partners lifted its McKesson target to $1200 from $1070 and Edwards Lifesciences to $112 from $101.

published on Newsmetry
original source published

the same feed is available to bots and dashboards through the api. connect the api →

Newsmetry newsroom

what happened

Dow Jones Newswires, citing Benzinga, reports that Leerink Partners raised its price target on McKesson shares to $1200 from $1070. On the same day the firm lifted its target for Edwards Lifesciences to $112 from $101. The report covers only the target changes and gives no reasoning or rating details.

why it matters

Analyst target revisions like these are a routine part of the ratings flow. They rarely move the broader market on their own, but they show how analysts view the outlook for healthcare companies. Price reaction usually depends on earnings and fresh company data.

tags

Analyst RatingStockUnited StatesIsrael

instruments

McKessonEdwards Lifesciences

sources

  1. McKesson Price Target Raised to $1200.00/Share From $1070.00 by Leerink Partners — Dow Jones Newswires, 5 November 2026 at 20:03 UTC
  2. Edwards Lifesciences Price Target Raised to $112.00/Share From $101.00 by Leerink Partners — Dow Jones Newswires, 5 November 2026 at 20:00 UTC
  3. Myriad Genetics Price Target Raised to $8.00/Share From $5.00 by Leerink Partners — Dow Jones Newswires, 5 November 2026 at 20:06 UTC
  4. PROCEPT BioRobotics Price Target Raised to $22.00/Share From $20.00 by Leerink Partners — Dow Jones Newswires, 5 November 2026 at 20:13 UTC
  5. Insulet Price Target Raised to $167.00/Share From $143.00 by Leerink Partners — Dow Jones Newswires, 5 November 2026 at 20:11 UTC
  6. McKesson Price Target Raised to $1200.00/Share From $1006.00 by TD Cowen — Dow Jones Newswires, 5 November 2026 at 20:41 UTC
  7. Amneal Pharmaceuticals Price Target Raised to $25.00/Share From $23.00 by Leerink Partners — Dow Jones Newswires, 5 November 2026 at 21:15 UTC
  8. Exelixis Price Target Raised to $58.00/Share From $55.00 by Leerink Partners — Dow Jones Newswires, 5 November 2026 at 21:19 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗

related stories